Cervical cancer in central Central and Eastern Europe and Central Asia
Tuesday, December 4, 2018
Scientific Session
•
SS 05
•
8:15 AM
>
9:45 AM
•
Cervical cancer in central Central and Eastern Europe and Central Asia
•
Auditorium II
Cervical cancer incidence and mortality are higher in Central and Eastern Europe (CEE) countries than elsewhere in Europe and are rising in certain countries, partly due to an absence of screening interventions that are, at best, opportunistic with relatively low coverage and quality. In CEE approximately 40,000 women develop cervical cancer and 20,000 die from the disease yearly and cumulative risk for getting the disease in Eastern Europe is 4 to 5 times higher than in Western and Nordic Europe. The session will summarize epidemiological situation in CEE countries, review current status of cervical cancer screening practices and of vaccination implementation in the region and will propose urgent need for coordinated programs of HPV vaccination and HPV-based organized screening in CEE region as the only way forward.
8:15 AM
•
SS 05-01
•
Cervical cancer in Central and Eastern Europe and Central Asia: how big is the problem?
>
S.
Salvatore
VACCARELLA
8:28 AM
•
SS 05-02
•
Preventable fractions of cervical cancer via effective screening in Central and Eastern Europe and Central Asia
>
F.
Freddie
BRAY
8:41 AM
•
SS 05-03
•
Cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe
>
K.
Katja
SEME
8:54 AM
•
SS 05-04
•
Cervical cancer screening practices and current status of vaccination implementation in the Russian Federation
>
I.
Ilya
Olkov
9:07 AM
•
SS 05-05
•
Cost-effectiveness of integrated cervical cancer prevention in Central and Eastern Europe and Central Asia
>
H.
Hans
BERKHOF
9:20 AM
•
SS 05-06
•
The need for coordinated programs of vaccination and screening in Central and Eastern Europe and Central Asia
>
X.
Xavier
BOSCH
9:33 AM
•
SS 05-07
•
Discussion
|